Antipsychotic treatment for late-life schizophrenia (Q34749227)

4 August 2017

1 reference

title

Antipsychotic treatment for late-life schizophrenia (English)

1 reference

4 August 2017

0 references

2

Dilip V Jeste

1 reference

4 August 2017

Jeremy A Sable

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Current Psychiatry Reports

4 August 2017

published in

1 reference

4 August 2017

volume

4

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

299-306

1 reference

Older patients with schizophrenia: challenges in the coming decades

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Treatment of late-life schizophrenia with neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Late-onset schizophrenia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Longitudinal studies of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

The heterogeneity of the long-term course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

A selective review of recent North American long-term followup studies of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

The manifestations of schizophrenia in late life: a dearth of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Catamnestic long-term study on the course of life and aging of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Late onset schizophrenia-like illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Clozapine Therapy for Older Veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Conventional vs. newer antipsychotics in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

A chart review study of late-onset and early-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-996-0050-Y

Risperidone in the treatment of elderly patients with psychotic disorders

21 January 2018

1 reference

12 December 2020

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

1 reference

12 December 2020

Stability and course of neuropsychological deficits in schizophrenia

1 reference

12 December 2020

Nondementia Nonpraecox Dementia Praecox?: Late-Onset Schizophrenia

1 reference

12 December 2020

Drug treatment as a cause of falls in old age. A review of the offending agents

1 reference

12 December 2020

Prospective study of tardive dyskinesia incidence in the elderly

1 reference

12 December 2020

Prospective study of tardive dyskinesia in the elderly: rates and risk factors

1 reference

12 December 2020

Can schizophrenia begin after age 44?

1 reference

12 December 2020

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

12 December 2020

Risperidone-induced neuroleptic malignant syndrome

1 reference

12 December 2020

Drug treatment of schizophrenia and delusional disorder in late life

1 reference

12 December 2020

Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group

1 reference

12 December 2020

The efficacy, safety, and tolerability of antipsychotics in the elderly

1 reference

12 December 2020

Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesia

1 reference

12 December 2020

Tardive dyskinesia: prevalence, incidence, and risk factors

1 reference

12 December 2020

Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia

1 reference

12 December 2020

Late-onset schizophrenia. Studying clinical validity

1 reference

12 December 2020

BEHAVIORAL IMPROVEMENT IN THE OLDER SCHIZOPHRENIC PATIENT: DRUG AND SOCIAL THERAPIES

1 reference

12 December 2020

Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.

1 reference

12 December 2020

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations

1 reference

12 December 2020

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

12 December 2020

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group

1 reference

12 December 2020

Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases

1 reference

12 December 2020

The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia

1 reference

12 December 2020

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

12 December 2020

Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics

1 reference

12 December 2020

Impairment of the semantic network in schizophrenia.

1 reference

12 December 2020

Olanzapine-induced neuroleptic malignant syndrome

1 reference

12 December 2020

Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients.

1 reference

12 December 2020

Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients

1 reference

12 December 2020

Management of late-life psychosis

1 reference

12 December 2020

Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades

1 reference

12 December 2020

A randomized controlled pilot study of cognitive behavioral social skills training for older patients with schizophrenia

1 reference

12 December 2020

High- and Low-Potency Neuroleptics in Elderly Psychiatric Patients

1 reference

12 December 2020

Schizophrenia in late life: findings challenge traditional concepts

1 reference

12 December 2020

The natural history of mental disorder in old age.

1 reference

12 December 2020

New atypical antipsychotics. Experience and utility in the elderly

1 reference

12 December 2020

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

1 reference

12 December 2020

10.1007/S11920-996-0050-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1003756987

0 references

1 reference